ArticleEsophagus : official journal of the Japan Esophageal Society2026
Clinical diagnostic accuracy and lymph node metastasis patterns in clinical T1bN0M0 esophageal squamous cell carcinoma: a supplementary analysis of JCOG1409.
Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundAccording to the results of JCOG0502, esophagectomy and chemoradiotherapy are standard treatments for cT1bN0M0 esophageal squamous cell carcinoma (ESCC). In the trial, 27.0% of patients developed pathological lymph node metastases (LNM). As imaging has advanced, diagnostic accuracy may have improved as well. This supplementary analysis of JCOG1409 aimed to clarify the clinical diagnostic accuracy, including the lymph node metastasis-positive proportion and lymph node metastasis sites, for clinical T1bN0M0 ESCC.
methodsData from JCOG1409, which compared thoracoscopic and open esophagectomy for ESCC, were analyzed, focusing on patients with cT1bN0M0 disease. All patients underwent esophagectomy with D2 or greater lymph node dissection, and none received neoadjuvant treatment. Pathologic findings, including the pathologic tumor depth of the primary tumor, station, and frequencies of LNM, were assessed.
resultsA total of 89 patients were included in this analysis. The diagnosis of pT1b was 66.3% (59/89 patients). For N-stage accuracy, 17 (19.1%) of the 89 clinical N0 patients had pathologic LNM. LNM was confined to the cervical and upper mediastinal regions in upper thoracic tumors, and to the upper mediastinal and abdominal regions in lower thoracic tumors. Conversely, middle thoracic tumors exhibited widespread multi-field LNM.
conclusionThe clinical diagnosis of T1bN0M0 is still not accurate, although the diagnostic accuracy for LNM in JCOG1409 improved compared to that in JCOG0502.
Indexed as
Identifiers
42412141What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.